Immunologic uniqueness of the genital tract: Challenge for vaccine development

American Journal of Reproductive Immunology

Volumn 53, Issue 5, 2005, Pages 208-214

  Mestecky, Jiri ^a   Moldoveanu, Zina ^a   Russell, Michael W ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Human immunodeficiency virus; Immune responses; Mucosal immunity; Vaccines

Indexed keywords

ANTIGEN; BACTERIAL VACCINE; CELL ADHESION MOLECULE; CHOLERA TOXIN; CHOLERA TOXIN B SUBUNIT; GLYCOPROTEIN GP 160; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; NEUTRALIZING ANTIBODY; POLIOMYELITIS VACCINE; RECOMBINANT VACCINE; SALMONELLOSIS VACCINE; SECRETORY IMMUNOGLOBULIN; VIRUS VACCINE;

CANARYPOX VIRUS; CELLULAR IMMUNITY; CHLAMYDIA TRACHOMATIS; DRUG DELIVERY SYSTEM; FEMALE; GENITAL SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOSTIMULATION; INTESTINE; MALE; NEISSERIA GONORRHOEAE; NONHUMAN; PAPILLOMA VIRUS; PEYER PATCH; PRIORITY JOURNAL; REVIEW; SEMINAL PLASMA; VACCINE PRODUCTION; VAGINA SECRETION;

EID: 17444394873     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2005.00267.x     Document Type: Review

References (71)

1. Russell MW, Sparling PF, Morrison RP, Cauci S, Fidel PL Jr, Martin D, Hook EW III, Mestecky J: Mucosal immunology of sexually transmitted diseases. In Mucosal Immunology, 3rd edn, J Mestecky, J Bienenstock, ME Lamm, L Mayer, JR McGhee, W Strober (eds). Elsevier Academic Press, Amsterdam, The Netherlands, 2005, pp 1693-1720.
2. Mestecky J, Moro I, Kerr M, Woof J: Mucosal immunoglobulins. In Mucosal Immunology, 3rd edn, J Mestecky, J Bienenstock, ME Lamm, L Mayer, JR McGhee, W Strober (eds). Elsevier Academic Press, Amsterdam, The Netherlands, 2005, pp 153-181.
3. Jackson S, Mestecky J, Moldoveanu Z, Spearman P: Appendix I: Collection and processing of human mucosal secretions. In Mucosal Immunology, 3rd edn, J Mestecky, J Bienenstock, ME Lamm, L Mayer, JR McGhee, W Strober (eds). Elsevier Academic Press, Amsterdam, The Netherlands, 2005, pp 1829-1839.
4. Kutteh WH, Prince SJ, Hammond KR, Kutteh CC, Mestecky J: Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation. Clin Exp Immunol 1996; 104:538-542.
5. Russell MW, Mestecky J: Humoral immune responses to microbial infections in the genital tract. Microbes Infect 2002; 4:667-677.
6. Wira C, Crane-Godreau MA, Grant KS: Endocrine regulation of the mucosal immune system in the female reproductive tract. In Mucosal Immunology, 3rd edn, J Mestecky, J Bienenstock, ME Lamm, L Mayer, JR McGhee, W Strober (eds). Elsevier Academic Press, Amsterdam, The Netherlands, 2005, pp 1661-1676.
7. Brandtzaeg P: The human mucosal B cell system. In Mucosal Immunology, 3rd edn, J Mestecky, J Bienenstock, ME Lamm, L Mayer, JR McGhee, W Strober (eds). Elsevier Academic Press, Amsterdam, The Netherlands, 2005, pp 617-654.
8. Crowley-Nowick PA, Bell M, Edwards RP, McCallister D, Gore H, Kanbour-Shakir A, Mestecky J, Partridge EE: Normal uterine cervix: characterization of isolated lymphocyte phenotypes and immunoglobulin secretion. Am J Reprod Immunol 1995; 34:241-247.
9. Boyaka PN, McGhee JR, Czerkinsky C, Mestecky J: Mucosal vaccines: an overview. In Mucosal Immunology, 3rd edn, J Mestecky, J Bienenstock, ME Lamm, L Mayer, JR McGhee, W Strober (eds). Elsevier Academic Press, Amsterdam, The Netherlands, 2005, pp 855-874.
10. Yeaman GR, Guyre PM, Fanger MW, Collins JE, White HD, Rathbun W, Orndorff KA, Gonzalez J, Stern JE, Wira CR: Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol 1997; 61:427-435.
11. Menge AC, Michalek SM, Russell MW, Mestecky J: Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to cholera toxin B subunit. Infect Immun 1993; 61:2162-2171.
12. Kutteh WH, Mestecky J, Wira CR: Mucosal immunity in the human female reproductive tract. In Mucosal Immunology, 3rd edn, J Mestecky, J Bienenstock, ME Lamm, L Mayer, JR McGhee, W Strober (eds). Elsevier Academic Press, Amsterdam, The Netherlands, 2005, pp 1631-1646.
13. McDermott MR, Brais LJ, Evelegh MJ: Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. J Gen Virol 1990; 71:1497-1504.
14. Parr EL, Bozzola JJ, Parr MB: Immunity to vaginal infection by herpes simplex virus type 2 in adult mice: characterization of the immunoglobulins in vaginal mucus. J Reprod Immunol 1998; 38:15-30.
15. Eriksson K, Quiding-Järbrink M, Osek J, Möller Å, Björk S, Holmgren J, Czerkinsky C: Specific-antibody-secreting cells in the rectums and genital tracts of non-human primates following vaccination. Infect Immun 1998; 66:5889-5896.
16. Wu HY, Abdu S, Stinson D, Russell MW: Generation of female genital tract antibody responses by local or central (common) mucosal immunization. Infect Immun 2000; 68:5539-5545.
17. Black CA, Rohan LC, Cost M, Watkins SC, Draviam R, Alber S, Edwards RP: Vaginal mucosa serves as an inductive site for tolerance. J Immunol 2000; 165:5077-5083.
18. Hedges SR, Mayo MS, Mestecky J, Hook EW, Russell MW: Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections. Infect Immun 1999; 67:3937-3946.
19. Pate MS, Hedges SR, Sibley DA, Russell MW, Hook EW, Mestecky J: Urethral cytokine and immune responses in Chlamydia trachomatis infected males. Infect Immun 2001; 69:7178-7181.
20. Bouvet J-P, Bélec L, Pirès R, Pillot J: Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination. Infect Immun 1994; 62:3957-3961.
21. Baba TW, Liska V, Hofmann-Lehmann R, Vlasak J, Xu W, Ayehunie S, Cavacini LA, Posner MR, Katinger H, Stiegler G, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Keeling ME, Lu Y, Wright JE, Chou TC, Ruprecht RM: Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med 2000; 6:200-206.
22. Mascola JR, Stiegler G, VanCott TC, Katinger H, Carpenter CB, Hanson CE, Beary H, Hayes D, Frankel SS, Birx DL, Lewis MG: Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 2000; 6:207-210.
23. Kantele A, Häkkinen M, Moldoveanu Z, Lu A, Savilahti E, Alvarez RD, Michalek S, Mestecky J: Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans. Infect Immun 1998; 66:5630-5635.
24. Wright PF, Mestecky J, McElrath MJ, Keefer MC, Gorse GJ, Goepfert PA, Moldoveanu Z, Schwartz D, Spearman PW, El Habib R, Spring MD, Zhu Y, Smith C, Flores J, Weinhold KJ: Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein. J Infect Dis 2004; 189:1221-1231.
25. Crowley-Nowick PA, Bell MC, Brockwell R, Edwards RP, Chen S, Partridge EE, Mestecky J: Rectal immunization for induction of specific antibody in the genital tract of women. J Clin Immunol 1997; 17:370-379.
26. Kutteh WH, Kantele A, Moldoveanu Z, Crowley-Nowick PA, Mestecky J: Induction of specific immune responses in the genital tract of women after oral or rectal immunization and rectal boosting with Salmonella typhi Ty 21a vaccine. J Reprod Immunol 2001; 52:61-75.
27. Nardelli-Haefliger D, Kraehenbuhl J-P, Curtiss R, Schödel F, Potts A, Kelly S, de Grandi P: Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain. Infect Immun 1996; 64:5219-5224.
28. Wu HY, Russell MW: Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun 1993; 61:314-322.
29. Gallichan WS, Rosenthal KL: Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 1995; 13:1589-1595.
30. Di Tommaso A, Saletti G, Pizza M, Rappuoli R, Dougan G, Abrignani S, Douce G, De Magistris MT: Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect Immun 1996; 64:974-979.
31. Russell MW, Moldoveanu Z, White PL, Sibert GJ, Mestecky J, Michalek SM: Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit. Infect Immun 1996; 64:1272-1283.
32. Johansson EL, Rask C, Fredriksson M, Eriksson K, Czerkinsky C, Holmgren J: Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect Immun 1998; 66:514-520.
33. Wu HY, Russell MW: Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system. Immunol Res 1997; 16:187-201.
34. Johansson EL, Rudin A, Wassén L, Holmgren J: Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology 1999; 96:272-277.
35. Bowman EP, Kuklin NA, Youngman KR, Lazarus NH, Kunkel EJ, Pan JL, Greenberg HB, Butcher EC: The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J Exp Med 2002; 195:269-275.
36. Lazarus NH, Kunkel EJ, Johnston B, Wilson E, Youngman KR, Butcher EC: A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts. J Immunol 2003; 170:3799-3805.
37. Bergquist C, Johansson EL, Lagergård T, Holmgren J, Rudin A: Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun 1997; 65:2676-2684.
38. Rudin G, Riise GC, Holmgren J: Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit. Infect Immun 1999; 67:2884-2890.
39. Johansson EL, Wassen L, Holmgren J, Jertborn M, Rudin A: Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect Immun 2001; 69:7481-7486.
40. Kozlowski PA, Williams SB, Lynch RM, Flanigan TP, Patterson RR, Cu-Uvin S, Neutra MR: Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J Immunol 2002; 169:566-574.
41. Quiding-Järbrink M, Nordström I, Granström G, Kilander A, Jertborn M, Butcher EC, Lazarovits AI, Holmgren J, Czerkinsky C: Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. J Clin Invest 1997; 99:1281-1286.
42. van Ginkel FW, Jackson RJ, Yuki Y, McGhee JR: Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J Immunol 2000; 165:4778-4782.
43. Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, Spyr C, Steffen R: Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004; 350:896-903.
44. Nawar H, Arce S, Russell MW, Connell TD: Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities. Infect Immun 2005; 73:1330-1342.
45. Eriksson AM, Schön KM, Lycke NY: The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues. J Immunol 2004; 173:3310-3319.
46. Cummins JE, Dezzutti CS: Sexual HIV-1 transmission and mucosal defense mechanisms. AIDS Rev 2000; 2:144-154.
47. Kozlowski PA, Neutra MR: The role of mucosal immunity in prevention of HIV transmission. Curr Mol Med 2003; 3:217-228.
48. Mestecky J, Jackson S, Moldoveanu Z, Nesbit LR, Kulhavy R, Prince SJ, Sabbaj S, Mulligan MJ, Goepfert PA: Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals. AIDS Res Hum Retroviruses 2004; 20:972-988.
49. Artenstein AW, VanCott TC, Sitz KV, Robb ML, Wagner KF, Veit SC, Rogers AF, Garner RP, Byron JW, Burnett PR, Birx DL: Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information. J Infect Dis 1997; 175:265-271.
50. Belec L, Georges AJ, Steenman G, Martin PM: Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. J Infect Dis 1989; 160:385-391.
51. Beyrer C, Artenstein AW, Rugpao S, Stephens H, VanCott TC, Robb ML, Rinkaew M, Birx DL, Khamboonruang C, Zimmerman PA, Nelson KE, Natpratan C: Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J Infect Dis 1999; 179:59-67.
52. Broliden K, Hinkula J, Devito C, Kiama P, Kimani J, Trabbatoni D, Bwayo JJ, Clerici M, Plummer F, Kaul R: Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers Immunol Lett 2001; 79:29-36.
53. Buchacz K, Parekh BS, Padian NS, van der Straten A, Phillips S, Jonte J, Holmberg SD: HIV-specific IgG in cervicovaginal secretions of exposed HIV-uninfected female sexual partners of HIV-infected men. AIDS Res Hum Retroviruses 2001; 17:1689-1693.
54. Devito C, Hinkula J, Kaul R, Kimani J, Kiama P, Lopalco L, Barass C, Piconi S, Trabattoni D, Bwayo JJ, Plummer F, Clerici M, Broliden K: Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. J Acquir Immune Defic Syndr 2002; 30:413-420.
55. Devito C, Hinkula J, Kaul R, Lopalco L, Bwayo JJ, Plummer F, Clerici M, Broliden K: Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS 2000; 14:1917-1920.
56. Dorrell L, Hessell AJ, Wang M, Whittle H, Sabally S, Rowland-Jones S, Burton DR, Parren PW: Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia. AIDS 2000; 14:1117-1122.
57. Fiore JR, Laddago V, Lepera A, La Grasta L, Di Stefano M, Saracino A, Lopalco P, Pastore G, Angarano G: Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding. New Microbiol 2000; 23:85-92.
58. Kaul R, Trabattoni D, Bwayo JJ, Arienti D, Zagliani A, Mwangi FM, Kariuki C, Ngugi EN, MacDonald KS, Ball TB, Clerici M, Plummer FA: HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999; 13:23-29.
59. Lizeng Q, Nilsson C, Sourial S, Andersson S, Larsen O, Aaby P, Ehnlund M, Bjorling E: Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals. J Virol 2004; 78:7016-7022.
60. Lu FX: Predominate HIV1-specific IgG activity in various mucosal compartments of HIV1-infected individuals. Clin Immunol 2000; 97:59-68.
61. Mazzoli S, Trabattoni D, Lo Caputo S, Piconi S, Ble C, Meacci F, Ruzzante S, Salvi A, Semplici F, Longhi R, Fusi ML, Tofani N, Biasin M, Villa ML, Mazzotta F, Clerici M: HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 1997; 3:1250-1257.
62. Raux M, Finkielsztejn L, Salmon-Ceron D, Bouchez H, Excler JL, Dulioust E, Grouin JM, Sicard D, Blondeau C: Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects. AIDS Res Hum Retroviruses 1999; 15:1365-1376.
63. Wright PF, Kozlowski PA, Rybczyk GK, Goepfert P, Staats HF, VanCott TC, Trabattoni D, Sannella E, Mestecky J: Detection of mucosal antibodies in HIV type 1-infected individuals. AIDS Res Hum Retroviruses 2002; 18:1291-1300.
64. Jackson S, Prince S, Kulhavy R, Mestecky J: False positivity of enzyme-linked immunosorbent assay for measurement of secretory IgA antibodies directed at HIV-1 antigens. AIDS Res Hum Retroviruses 2000; 16:595-602.
65. Raux M, Finkielsztejn L, Salmon-Ceron D, Bouchez H, Excler JL, Dulioust E, Grouin JM, Sicard D, Blondeau C: Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients. J Immunol Methods 1999; 222:111-124.
66. Jackson S, Moldoveanu Z, Mestecky J, Pitts AM, Eldridge JH, McGhee JR, Miller CJ, Marx PA: Decreased IgA-producing cells in the gut of SIV-infected rhesus monkeys. Adv Exp Med Biol 1995; 371B:1035-1038.
67. Israel ZR, Marx PA: Nonclassical mucosal antibodies predominate in genital secretions of HIV-1 infected chimpanzees. J Med Primatol 1995; 24:53-60.
68. Schafer F, Kewenig S, Stolte N, Stahl-Hennig C, Stallmach A, Kaup FJ, Zeitz M, Schneider T: Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques. Gut 2002; 50:608-614.
69. Skurnick JH, Palumbo P, DeVico A, Shacklett BL, Valentine FT, Merges M, Kamin-Lewis R, Mestecky J, Denny T, Lewis GK, Lloyd J, Praschunus R, Baker A, Nixon DF, Stranford S, Gallo R, Vermund SH, Louria DB: Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. J Infect Dis 2002; 185:428-438.
70. Lambert JS, Keefer M, Mulligan MJ, Schwartz D, Mestecky J, Weinhold K, Smith C, Hsieh R, Moldoveanu Z, Fast P, Forrest B, Koff W: A phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects. Vaccine 2001; 19:3033-3042.
71. Blattner WA, Schwartz D, Hone D, Zimmerman E, Nerhod L, Clyde T, Carruth L, Tackett C, Harro C, Clemmons ML, Lewis G, for the AIDS Vaccine Evaluation Group 028 Protocol Team: Safety and Immunogenicity of a Salmonella Vectored HIV Vaccine: AVEG 028. AIDS Vaccine 2003. Abstract 58LB, 2003, p. 62.